An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Patients With Renal Anemia
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
This observational study will investigate hemoglobin levels and Mircera (methoxy
polyethyleneglycol-epoetin beta) dose over time in patients with chronic kidney disease, and
compare standards of care between centers. Data from each patient will be collected over 12
months of Mircera therapy.